Fig. 1From: Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infantsSchematic flowchart shows the numbers of infants who were screened for eligibility, randomly assigned to the rhEPO or control group, and followed up to 45Â weeks of corrected age. ROP, retinopathy of prematurity; NEC, necrotizing enterocolitisBack to article page